| Literature DB >> 35218385 |
Jochen P Windfuhr1, Christian Günster2.
Abstract
PURPOSE: To longitudinally evaluate the impact of the COVID-19-pandemic on the incidence of inpatient tonsil surgery and outpatient primary care of sore throat in Germany.Entities:
Keywords: Antibiotics; COVID-19; Peritonsillar abscess; SARS-CoV-2; Tonsillectomy; Tonsillitis; Tonsillotomy
Mesh:
Year: 2022 PMID: 35218385 PMCID: PMC8881894 DOI: 10.1007/s00405-022-07308-8
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503
Total cases of tonsil surgery during the COVID-19 pandemic in Germany
| Category | Pre-restriction | Restriction cases | Post-restriction cases | |||
|---|---|---|---|---|---|---|
| Cases per week | Cases per week | Cases per week | ||||
| Tonsillectomy | ||||||
| All | 33,366 | 556.1 (77.9) | 775 | 110.7 (46.4) | 23,149 | 326.0 (69.2) |
| Gender | ||||||
| Female | 14,194 | 236.6 (37.6) | 398 | 56.9 (17.3) | 10,069 | 141.8 (27.5) |
| Male | 19,170 | 319.5 (46.3) | 377 | 53.9 (30.2) | 13,077 | 184.2 (44.2) |
| Age group (years) | ||||||
| 0–9 | 2021 | 33.7 (7.8) | 55 | 7.9 (4.3) | 1433 | 20.2 (9.4) |
| 10–17 | 4230 | 70.5 (20.6) | 76 | 10.9 (5.6) | 2473 | 34.8 (13.5) |
| 18–49 | 23,714 | 395.2 (65.7) | 440 | 62.9 (38.2) | 16,235 | 228.7 (49.1) |
| 50+ | 3401 | 56.7 (10.3) | 204 | 29.1 (5.9) | 3008 | 42.4 (7.6) |
| Adeno-tonsillectomy | ||||||
| All | 10,492 | 174.9 (25.0) | 174 | 24.9 (14.6) | 5325 | 75.0 (23.2) |
| Gender | ||||||
| Female | 5003 | 83.4 (12.5) | 87 | 12.4 (7.5) | 2466 | 34.7 (12.0) |
| Male | 5486 | 91.4 (15.5) | 87 | 12.4 (7.8) | 2859 | 40.3 (12.9) |
| Age group (years) | ||||||
| 0–9 | 5980 | 99.7 (15.7) | 98 | 14.0 (9.0) | 2664 | 37.5 (14.2) |
| 10–17 | 1508 | 25.1 (9.8) | 23 | 3.3 (2.9) | 716 | 10.1 (4.8) |
| 18–49 | 2840 | 47.3 (12.1) | 48 | 6.9 (4.1) | 1804 | 25.4 (8.7) |
| 50 | 164 | 2.7 (1.5) | 5 | 0.7 (1.0) | 141 | 2.0 (1.6) |
| Tonsillotomy | ||||||
| All | 24,053 | 400.9 (40.8) | 726 | 103.7 (47.5) | 16,478 | 232.1 (53.6) |
| Gender | ||||||
| Female | 13,958 | 232.6 (26.1) | 452 | 64.6 (28.3) | 9447 | 133.1 (33.0) |
| Male | 10,092 | 168.2 (18.4) | 274 | 39.1 (19.7) | 7031 | 99.0 (23.2) |
| Age group (years) | ||||||
| 0–9 | 20,104 | 335.1 (40.8) | 589 | 84.1 (45.8) | 12,243 | 172.4 (49.3) |
| 10–17 | 1327 | 22.1 (6.9) | 28 | 4.0 (1.9) | 882 | 12.4 (5.1) |
| 18–49 | 1709 | 28.5 (6.5) | 49 | 7.0 (2.7) | 2089 | 29.4 (6.8) |
| 50+ | 913 | 15.2 (4.3) | 60 | 8.6 (2.5) | 1264 | 17.8 (4.8) |
| Abscess-tonsillectomy | ||||||
| All | 9920 | 165.3 (14.7) | 751 | 107.3 (17.7) | 6966 | 98.1 (13.0) |
| Gender | ||||||
| Female | 5656 | 94.3 (10.6) | 435 | 62.1 (7.9) | 4113 | 57.9 (9.1) |
| Male | 4264 | 71.1 (7.9) | 316 | 45.1 (10.5) | 2853 | 40.2 (7.2) |
| Age group (years) | ||||||
| 0–9 | 471 | 7.9 (3.3) | 29 | 4.1 (4.3) | 122 | 1.7 (1.2) |
| 10–17 | 899 | 15.0 (3.8) | 54 | 7.7 (3.3) | 524 | 7.4 (2.9) |
| 18–49 | 6305 | 105.1 (12.2) | 482 | 68.9 (14.1) | 4104 | 57.8 (9.7) |
| 50+ | 2245 | 37.4 (7.3) | 186 | 26.6 (5.1) | 2216 | 31.2 (7.4) |
| Incisional drainage | ||||||
| All | 7996 | 133.3 (14.7) | 656 | 93.7 (17.0) | 6017 | 84.7 (13.2) |
| Gender | ||||||
| Female | 4566 | 76.1 (9.3) | 367 | 52.4 (5.3) | 3668 | 51.7 (9.7) |
| Male | 3429 | 57.2 (9.2) | 289 | 41.3 (12.4) | 2348 | 33.1 (6.4) |
| Age group (years) | ||||||
| 0–9 | 80 | 1.3 (1.0) | 6 | 0.9 (0.7) | 23 | 0.3 (0.6) |
| 10–17 | 470 | 7.8 (2.6) | 50 | 7.1 (3.0) | 333 | 4.7 (2.7) |
| 18–49 | 5397 | 90.0 (13.4) | 427 | 61.0 (12.2) | 3647 | 51.4 (9.5) |
| 50+ | 2049 | 34.2 (6.8) | 173 | 24.7 (4.6) | 2014 | 28.4 (5.3) |
Cases per week: mean, standard deviation (sd); diverse and unknown gender omitted, weeks of turn of year excluded
Trends in cases of tonsil surgery during the COVID-19 pandemic in Germany
| Category | Interrupted time series analysis | |||||
|---|---|---|---|---|---|---|
| Week | Restriction period | Post-restriction period | ||||
| RR (95% CI) | RR (95% CI) | RR (95% CI) | ||||
| Tonsillectomy | ||||||
| All | 0.996 (0.994–0.997) | * | 0.236 (0.187–0.298) | * | 0.824 (0.734–0.924) | * |
| Gender | ||||||
| Female | 0.996 (0.994–0.997) | * | 0.290 (0.235–0.358) | * | 0.853 (0.762–0.955) | 0.01 |
| Male | 0.996 (0.994–0.997) | * | 0.197 (0.149–0.262) | * | 0.802 (0.703–0.915) | * |
| Age group (years) | ||||||
| 0–9 | 0.991 (0.988–0.993) | * | 0.317 (0.209–0.483) | * | 1.160 (0.929–1.449) | 0.19 |
| 10–17 | 0.995 (0.992–0.998) | * | 0.186 (0.110–0.314) | * | 0.707 (0.555–0.901) | 0.01 |
| 18–49 | 0.996 (0.994–0.997) | * | 0.191 (0.145–0.253) | * | 0.817 (0.721–0.926) | 0.00 |
| 50+ | 0.999 (0.997–1.000) | 0.06 | 0.525 (0.434–0.636) | * | 0.853 (0.746–0.974) | 0.02 |
| Adeno-tonsillectomy | ||||||
| All | 0.993 (0.992–0.995) | * | 0.178 (0.131–0.241) | * | 0.718 (0.624–0.826) | * |
| Gender | ||||||
| Female | 0.993 (0.991–0.995) | * | 0.185 (0.133–0.258) | * | 0.702 (0.600–0.820) | * |
| Male | 0.993 (0.992–0.995) | * | 0.171 (0.120–0.244) | * | 0.733 (0.626–0.859) | * |
| Age group (years) | ||||||
| 0–9 | 0.992 (0.990–0.994) | * | 0.179 (0.127–0.251) | * | 0.664 (0.565–0.779) | * |
| 10–17 | 0.992 (0.988–0.996) | * | 0.183 (0.091–0.366) | * | 0.717 (0.524–0.979) | 0.04 |
| 18–49 | 0.995 (0.993–0.998) | * | 0.171 (0.109–0.270) | * | 0.815 (0.667–0.995) | 0.04 |
| 50+ | 0.998 (0.991–1.004) | 0.46 | 0.253 (0.093–0.693) | 0.01 | 0.889 (0.519–1.523) | 0.67 |
| Tonsillotomy | ||||||
| All | 0.997 (0.995–0.998) | * | 0.283 (0.231–0.348) | * | 0.734 (0.654–0.824) | * |
| Gender | ||||||
| Female | 0.996 (0.995–0.998) | * | 0.304 (0.246–0.377) | * | 0.736 (0.651–0.834) | * |
| Male | 0.997 (0.995–0.998) | * | 0.254 (0.202–0.320) | * | 0.732 (0.647–0.827) | * |
| Age group (years) | ||||||
| 0–9 | 0.996 (0.994–0.997) | * | 0.283 (0.224–0.357) | * | 0.707 (0.619–0.807) | * |
| 10–17 | 1.000 (0.996–1.003) | 0.77 | 0.191 (0.109–0.334) | * | 0.579 (0.441–0.759) | * |
| 18–49 | 1.001 (0.999–1.003) | 0.49 | 0.243 (0.169–0.349) | * | 0.990 (0.834–1.175) | 0.91 |
| 50+ | 1.003 (1.000–1.005) | 0.02 | 0.560 (0.411–0.763) | * | 0.953 (0.780–1.165) | 0.64 |
| Abscess-tonsillectomy | ||||||
| All | 0.999 (0.999–1.000) | 0.30 | 0.670 (0.605–0.741) | * | 0.607 (0.560–0.658) | * |
| Gender | ||||||
| Female | 1.000 (0.999–1.001) | 0.69 | 0.681 (0.602–0.769) | * | 0.613 (0.556–0.676) | * |
| Male | 0.999 (0.998–1.000) | 0.19 | 0.655 (0.570–0.753) | * | 0.598 (0.535–0.668) | * |
| Age group (years) | ||||||
| 0–9 | 0.997 (0.993–1.002) | 0.24 | 0.552 (0.345–0.881) | 0.01 | 0.289 (0.191–0.436) | * |
| 10–17 | 0.999 (0.996–1.002) | 0.66 | 0.531 (0.383–0.737) | * | 0.519 (0.405–0.666) | * |
| 18–49 | 0.999 (0.998–1.000) | 0.07 | 0.712 (0.623–0.813) | * | 0.596 (0.535–0.663) | * |
| 50+ | 1.001 (1.000–1.003) | 0.15 | 0.654 (0.541–0.789) | * | 0.720 (0.623–0.833) | * |
| Incisional drainage | ||||||
| All | 1.000 (0.999–1.001) | 0.87 | 0.721 (0.634–0.819) | * | 0.629 (0.567–0.697) | * |
| Gender | ||||||
| Female | 1.000 (0.999–1.002) | 0.70 | 0.712 (0.616–0.825) | * | 0.658 (0.586–0.739) | * |
| Male | 1.000 (0.998–1.002) | 0.88 | 0.730 (0.615–0.867) | * | 0.588 (0.510–0.678) | * |
| Age group (years) | ||||||
| 0–9 | 1.007 (0.996–1.017) | 0.20 | 0.362 (0.141–0.927) | 0.03 | 0.150 (0.059–0.377) | * |
| 10–17 | 0.998 (0.994–1.002) | 0.37 | 0.982 (0.657–1.469) | 0.93 | 0.684 (0.478–0.977) | 0.04 |
| 18–49 | 1.000 (0.999–1.002) | 0.81 | 0.701 (0.599–0.820) | * | 0.568 (0.500–0.646) | * |
| 50+ | 1.000 (0.999–1.002) | 0.87 | 0.731 (0.612–0.874) | * | 0.796 (0.694–0.914) | 0.00 |
Reference period: pre-restriction; diverse and unknown gender omitted
RR relative risk
*< 0.001
Fig. 1Association of the COVID-19 pandemic with the weekly caseload of tonsil surgery in Germany between January 2019 and September 2021
Fig. 2Gender-specific reduction of doctor contacts in 2020 with or without antibiotic prescription compared to 2019. The diagram delineates a female preponderance and a significant reduction after the first lockdown (March 2020), particularly when antibiotic prescriptions were considered. Thereafter, the number of doctor contacts remained on a lower level. m male f female, w/o without, /w with, AB antibiotics
specific reduction of doctor contacts in 2020 with or without antibiotic prescription compared to 2019
| Age | All | With antibiotic prescription | ||||||
|---|---|---|---|---|---|---|---|---|
| Q1 (%) | Q2 (%) | Q3 (%) | Q4 (%) | Q1 (%) | Q2 (%) | Q3 (%) | Q4 (%) | |
| Male | ||||||||
| 0–9 | − 8 | − 71 | − 44 | − 58 | − 11 | − 78 | − 61 | − 67 |
| 10–19 | − 6 | − 72 | − 24 | − 46 | − 8 | − 74 | − 43 | − 62 |
| 20–29 | − 2 | − 57 | − 37 | − 47 | − 4 | − 61 | − 46 | − 56 |
| 30–39 | 2 | − 55 | − 34 | − 47 | − 1 | − 63 | − 47 | − 59 |
| 40–49 | − 2 | − 48 | − 29 | − 42 | − 6 | − 58 | − 43 | − 55 |
| 50–59 | − 4 | − 39 | − 25 | − 39 | − 8 | − 53 | − 39 | − 54 |
| 60–69 | − 3 | − 34 | − 22 | − 36 | − 11 | − 52 | − 35 | − 54 |
| 70–79 | − 12 | − 29 | − 18 | − 34 | − 19 | − 46 | − 28 | − 53 |
| 80–89 | − 5 | − 22 | − 9 | − 27 | − 12 | − 42 | − 22 | − 46 |
| 90+ | − 3 | − 25 | − 16 | − 34 | − 5 | − 40 | − 45 | − 46 |
| Total | − 4 | − 60 | − 34 | − 48 | − 7 | − 67 | − 48 | − 60 |
| Female | ||||||||
| 0–9 | − 9 | − 71 | − 41 | − 60 | − 12 | − 78 | − 59 | − 69 |
| 10–19 | − 6 | − 68 | − 24 | − 44 | − 8 | − 71 | − 40 | − 57 |
| 20–29 | − 2 | − 58 | − 33 | − 46 | − 4 | − 63 | − 42 | − 55 |
| 30–39 | 5 | − 58 | − 32 | − 46 | 2 | − 67 | − 46 | − 59 |
| 40–49 | 2 | − 46 | − 25 | − 40 | − 2 | − 59 | − 41 | − 54 |
| 50–59 | − 1 | − 43 | − 26 | − 41 | − 6 | − 59 | − 43 | − 57 |
| 60–69 | − 2 | − 37 | − 21 | − 36 | − 9 | − 55 | − 40 | − 54 |
| 70–79 | − 11 | − 30 | − 18 | − 36 | − 14 | − 48 | − 33 | − 55 |
| 80–89 | − 9 | − 22 | − 14 | − 28 | − 15 | − 40 | − 29 | − 49 |
| 90+ | − 10 | − 26 | 1 | − 28 | − 18 | − 35 | − 13 | − 49 |
| Total | − 3 | − 58 | − 30 | − 47 | − 6 | − 67 | − 45 | − 59 |
Q Quarter